Prescription Required.Why?
Is the active pharmaceutical ingredient (api).
Treatment of mild to moderate COVID-19 in specific patient populations (as per healthcare professional guidance). Note: Favipiravir's efficacy and use in COVID-19 treatment is subject to ongoing research and may vary by region and guidelines.
Favi Amps 800mg Tablet (Favipiravir) is a viral RNA polymerase inhibitor. It interferes with the replication of RNA viruses, including some influenza viruses and certain other RNA viruses. In the context of COVID-19, its mechanism involves inhibiting the RNA-dependent RNA polymerase of SARS-CoV-2, thus hindering viral replication.
Store in a cool, dry place, away from direct sunlight and moisture. Keep out of reach of children. Follow specific storage instructions on the product label.
Dosage and administration vary depending on the specific formulation, patient condition, and healthcare professional's instructions. Never adjust the dosage without consulting a doctor.
Always follow the prescribed dosage and regimen precisely.
Nausea
Vomiting
Diarrhea
Abdominal pain
Headache
Increased liver enzymes (in some cases)
Rash
Color changes in urine (yellowbrown)
Elevated uric acid levels (hyperuricemia)
Alcohol consumption may exacerbate some side effects. Consult your doctor.
Favipiravir may cause dizziness or drowsiness in some individuals. Avoid driving or operating machinery if affected.
Use is generally not recommended during pregnancy or breastfeeding. Consult your doctor for specific advice.
Use in children is determined based on specific guidelines and should only be done under strict medical supervision.
Patients with kidney impairment may require dosage adjustments. Renal function should be monitored.
Liver function should be monitored, especially in patients with pre-existing liver conditions. Dosage adjustment may be necessary.
Please consult your healthcare provider or refer to the official prescribing information for detailed information and updated guidelines.
